InsidersTradesSigma
5 insiders bought €77.0M of shares over the last 90 days, the latest filed 30 Sept 2026.
Cluster: 5 buyers in 30 daysTrack the ADARx Pharmaceuticals, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). The latest transaction was reported on 30 September 2026 (C). Among the most active insiders: GORDON CARL L. Every trade is openly available.
51
Insider Decl.
n/a
Thresholds
€77M
13 ops.
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 September 2026
Declarations51 total
7,127,019 sharesCommon StockSEC:0000947871-26-000912:0
1,333,975 sharesCommon StockSEC:0000947871-26-000912:1
513,067 sharesCommon StockSEC:0000947871-26-000912:2
256,448 sharesCommon StockSEC:0000947871-26-000912:3
61,516 shares@ US$17.00Common StockSEC:0000947871-26-000912:4
Canonical exit: 27 Dec 2026 (T+90)
10,690,530 sharesCommon StockSEC:0000947871-26-000911:0
2,000,962 sharesCommon StockSEC:0000947871-26-000911:1
769,601 sharesCommon StockSEC:0000947871-26-000911:2
564,187 sharesCommon StockSEC:0000947871-26-000911:3
300,249 shares@ US$17.00Common StockSEC:0000947871-26-000911:4
Canonical exit: 27 Dec 2026 (T+90)
7,127,019 sharesCommon StockSEC:0000947871-26-000911:5
1,333,975 sharesCommon StockSEC:0000947871-26-000911:6
513,067 sharesCommon StockSEC:0000947871-26-000911:7
256,448 sharesCommon StockSEC:0000947871-26-000911:8
61,516 shares@ US$17.00Common StockSEC:0000947871-26-000911:9
Canonical exit: 27 Dec 2026 (T+90)
588,235 shares@ US$17.00Common StockSEC:0000947871-26-000911:10
Canonical exit: 27 Dec 2026 (T+90)
10,690,530 sharesCommon StockSEC:0000947871-26-000910:0
2,000,962 sharesCommon StockSEC:0000947871-26-000910:1
769,601 sharesCommon StockSEC:0000947871-26-000910:2
564,187 sharesCommon StockSEC:0000947871-26-000910:3
300,249 shares@ US$17.00Common StockSEC:0000947871-26-000910:4
Canonical exit: 27 Dec 2026 (T+90)
7,127,019 sharesCommon StockSEC:0000947871-26-000910:5
1,333,975 sharesCommon StockSEC:0000947871-26-000910:6
513,067 sharesCommon StockSEC:0000947871-26-000910:7
256,448 sharesCommon StockSEC:0000947871-26-000910:8
25 of 51 declarations
About ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for serious diseases. It is listed on NASDAQ under the ticker ADAR.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations